How many investments has First In Ventures made?

First In Ventures has 30 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.

What stage does First In Ventures invest at?

First In Ventures invests at the Pre-Seed, Seed stages.

What is First In Ventures's typical check size?

First In Ventures typically writes checks of $50K – $200K.

Where is First In Ventures located?

First In Ventures is headquartered in Middletown, US.

Does First In Ventures lead rounds?

Yes, First In Ventures leads investment rounds.

Who does First In Ventures co-invest with?

First In Ventures most often shares deals with Better Ventures Central Llc, Illumina Ventures, Entrepreneur First, among 29 tracked co-investors.

First In Ventures

Venture capitalActively deploying

Middletown · Pre-Seed–Seed · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into First In Ventures

873 people in our graph share verified history with the First In Ventures team — schools, employers, funds. One of them is your warm intro.

Iñigo Alberolaunlockedknows Kyle Rusconi · together at BNP Paribas CIB (overlapped)

knows the team · via Nuclear Power School - Naval Nuclear Power Training Command (NNPTC)

×10knows the team · via United States Navy

✨ Fox Verdict

Investment thesis

A Middletown, Delaware–based firm specializing in early-stage biotech and life sciences.

Invests inAI & Machine Learning Biotech Data & Infrastructure Healthtech Medical Devices Middletown United States

Source: firm website, verified Aug 7, 2026.

Leave your own feedback

Stage

Pre-Seed–Seed

Check

$50K – $200K

Middletown, Delaware, US

Leads rounds

Leads

Instruments

Equity

Founded

2020

Last 12 months

1 investment

Tracked investments

IPOs

Acquisitions

Team · 7 people

from the firm's website & public directories

R McPherson Forbes· General Partner

Kyle Rusconi· Founder· Concord, Massachusetts, United Statesin

Founder of First In Ventures who began his career on early high-frequency trading desks and led trading teams across Asia and North America over seventeen years in banking. He is now CEO of Cognitive Genetics, which went through the Illumina Accelerator, an experience that inspired the creation of First In Ventures.

Scott Roth· Managing Member· Greenwich, CTin

An investor who founded two large institutional hedge funds (Severn River and Sagamore Hill) managing billions in assets from 1999 to 2014, and now runs his family office investing in public and private securities. He previously worked as a nuclear engineer for the Navy, a proprietary trader at Goldman Sachs, and attended Harvard Business School.

Andrew Sieghart· Investment Committee

A former Lehman Brothers executive in global real estate and principal transactions, later holding senior roles at Nomura Securities and G2 Investment Group focused on structured asset-based equity and debt investments. He is currently Managing Partner at Framework Capital Partners, a family office.

Richard D. Levinson· Investment Committee

A founding partner of Canaras Capital Management, a New York SEC RIA focused on corporate credit, and a principal of Sage Group advising on structured finance. He previously spent 18 years at Citibank in senior treasury and structured finance roles and holds degrees from Union College and the Wharton School.

Ven Medabalmi· Investment Committee

A serial entrepreneur and operator who invests through his family office with a portfolio of over 50 startup investments. He holds bioengineering and law degrees from the University of Pennsylvania and Columbia University, with experience spanning startups, IP and venture law, and operational management.

Richard Thoms· Executive Officer

What they invest in

from 24 of 30 portfolio companies

Biotech ×20Healthtech ×12AI & Machine Learning ×10Medical Devices ×8Digital Health ×7Deep Tech ×6Enterprise Software ×3AgTech ×2

HQs:United States×9United Kingdom×2India×1South Africa×1

Who they back

founder profiles across 10 portfolio companies

40%

solo founders

4 of 10 mapped founding teams

45%

repeat founders

of 11 founders with career history

Founding team size:solo founder×42 founders×43 founders×2

What their founders studiedfrom 12 founders with field-of-study data

Life Sciences ×5Engineering ×4Computer Science ×2

Where their founders worked beforefrom 11 founders with career history

Technion ×2Yale University ×2

Investments · 30 tracked

founders shown can be your intro path

By year:2025 · 1 2023 · 2 2022 · 2 2021 · 1 2020 · 17 dated

Humacytehumacyte.com in 𝕏NASDAQ: HUMA

Humacyte is a regenerative medicine company that develops a bioengineered, human-derived Acellular Tissue Engineered Vessel (ATEV) along with a scalable cell sourcing and manufacturing platform.

BiotechHealthtechMedical DevicesMorrisville, US

Laura E. Niklason(Director)in Laura Niklason, MD, PhD(Founder)inTed Lithgow(Executive Officer)in Paul Boyer(Executive Officer)inCarrie S. Cox(Executive Officer, Director)Dale A. Sander(Chief Financial Officer, Chief Corporate Development Officer and Treasurer)in

Co-investorsFresenius Medical Care Ventures Oberland Capital

Pluton Biosciencesplutonbio.com in✓ verified

Pluton is developing a sun-powered, soil-surface biological nutrient system that uses photosynthetic microbial consortia to fix atmospheric nitrogen, improve phosphorus availability, and add carbon to soil for crop growers.

AgTechBiotechClimate TechSt. Louis, US

Barry Goldman(Co-founder)inElizabeth Gallegos(Chief Executive Officer)in Jerry Steiner(Executive Chair)in Charlie Walch(Executive Officer, Director)inGlendon Schuster(Director)

Co-investorsIllumina Ventures Radicle Growth Fall Line Capital Grantham Foundation RA Capital The Yield Lab +3 more

Gliknikgliknik.comJun 2023

Baltimore-based immunology company focused on treatments for cancer and autoimmune disorders; raised an $11.5 million Series C led by First In Ventures.

BiotechBaltimore, US

David S. Block(Executive Officer, Director)Elizabeth C. Block(Executive Officer)Raymond Shinazi(Director)Joseph Klein(Director)Mark Lerner(Director)

BoardCharles Polsky(Director)

Board seat Kyle Rusconi· per SEC Form D

Co-investorsBrace Pharma

4BaseCare4basecare.com in

4baseCare delivers personalized cancer care using genomic data, AI analytics, and clinico-genomic datasets tailored to different populations.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Hitesh Goswami(Founder/CEO)in Kshitij Rishi(COO)in Puneet Pantane(CDO)inDr. Giridharan Periyasamy

Co-investorsgrowX Ventures Merak Ventures Mount Judi Ventures Season Two Ventures Yali Capital

Adluminadlumin.com 𝕏Nov 2023 · $70M

N-able delivers unified cybersecurity and data protection solutions including endpoint management (N-central), AI-powered threat detection and response (Adlumin), and disaster recovery services (Cove).

AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareAlexandria, US

Robert S. Jonhston(Executive Officer, Director)

Co-investorsBankTech Ventures JHH vc Syn Ventures Seed Management Llc First In Leawood Venture Capital Llc

Antithesisantithesis.com in 𝕏Dec 2025

Antithesis provides deterministic simulation testing software that automatically finds and reproduces bugs in mission-critical software systems.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaS

Will Wilson(CEO & Co-Founder)inDave Scherer(Co-Founder)Nick Lavezzo(Founder)in

Co-investorsAmplify Partners Tamarack Global Boulder Ventures Frontline Ventures Nat Turner Olima Ventures +4 more

Biotaxbiotax.co in

EcoBiotaX develops a microbial ecology platform that uses AI (its ecoSat computational platform) and biological methods to discover and construct natural bacterial communities for specific biological functions.

AgTechAI & Machine LearningBiotech

Naama Geva-Zatorsky(Co-Founder)in Shay Hilel(Co-Founder & CEO)in Dean Light(Co-Founder & CTO)in

Co-investorsZORA

Broken String Biosciencesbrokenstringbio.com in

Broken String Biosciences develops tools for genome-wide on- and off-target analysis in gene editing, enabling in-house detection and characterization of gene editing-induced DNA breaks.

AI & Machine LearningBiotechDeep Tech

Co-investorsHeran Partners Illumina Ventures Korys Mérieux Equity Partners

Celldomcelldom.com in

CellDom develops CloneXplorer, a live single-cell assay platform combining functional imaging, molecular readouts, and integrated cell retrieval for high-resolution cell analysis.

BiotechDeep TechHardwareMedical Devices

Co-investorsTSVC

Felix Biotechnologyfelixbt.com in 𝕏Defunct

Felix Biotechnology develops a digital platform for designing viruses intended to combat antimicrobial resistance.

BiotechHealthtechSan Francisco, US

Robert McBride(Founder)in Vivek Mutalik(Founder)inPaul Turner(Founder)in

Co-investorsPoint72 Ventures Y Combinator Agrolimen Ventures Pioneer

FlightPathflightpath.bio in

Flightpath Biosciences develops microbiome-sparing, pathogen-specific drug candidates to treat infection-associated diseases by selectively targeting harmful bacteria while preserving healthy microbial communities.

BiotechDeep TechDigital HealthHealthtechMedical DevicesBirmingham, US

Matt Tindall(Founder)inMark P. de Souza(Executive Officer, Director)

BoardCurtis Scribner(Director)Cristina Larkin(Director)

Co-investorsID Ventures Michigan Rise WMU Biosciences Research & Commercialization Center Active Capital

flowscopeflowscope.com inSeed

Flowscope deploys AI agents that learn how businesses operate and automate work on top of existing systems within days.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSan Francisco, US

Samuel Mirpuri(Founder)in Javier Leguina(Founder)in

Co-investorsY Combinator

Futuragenomicsfuturagenomics.com

Futura Genomics provides accredited genetic testing services that deliver personalized health and ancestry insights tailored to diverse populations, with particular focus on African heritage.

BiotechConsumerDigital HealthHealthtech

Lassogenlassogen.com in 𝕏Sep 2020

Lassogen engineers lasso peptides — structurally unique 3D scaffolds — into therapeutics it calls Lassotides, designed to combine the strengths of antibodies and small molecules.

AI & Machine LearningBiotechSan Diego, US

Mark J Burk(Executive Officer)in

Co-investorsBetter Ventures Central Llc Playground Global

Lightspeedbiolightspeedbio.com in 𝕏

Alpenglow Biosciences develops the Aurora 3D spatial biology platform, combining open-top light-sheet microscopy, volumetric data processing, and AI analysis to turn intact tissue into quantitative 3D data.

AI & Machine LearningBiotechMedical Devices

Mabletrymable.com in 𝕏Jul 2022 · $3.2MAcquired

Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesLondon, GB

Roman Rothaermel(Founder)in Inna Thalmann(Founder)inChris EijsboutsinKumeren Govnder

Co-investorsInitialized Capital Underscore VC Venrock Y Combinator Arkitekt Ventures Harvard Management Company

Medicmedic-life-sciences.com in

Medic Life Sciences applies CRISPR functional genomics in 3D patient tumor-like cancer models to identify biomarkers, synthetic lethality, and resistance mutations for oncology drug development.

BiotechDeep TechHealthtech

Kyuho Han(Chief Executive Officer/Co-Founder)Hong-Pyo Lee(Chief Technology Officer/Co-Founder)

Co-investorsBig Basin Capital Sazze

Mitra Biomitrabio.tech in 𝕏

Mitra develops a non-invasive skin diagnostics platform that combines clinical trials, skin sampling, next-generation sequencing, and data science to guide the design of age-rejuvenating skincare compounds.

BiotechDeep TechDigital HealthHealthtechLongevityMedical DevicesLondon, GB

Shakiba Kaveh(CEO)in Cristiana Banila(CTO)in

Co-investorsEntrepreneur First Merian Ventures

MultiplAI Healthmultiplaihealth.com in 𝕏

MultiplAI Health is developing an RNA-sequencing and AI-based whole blood screening test to detect complex diseases, with a focus on cardiovascular disorders and cancer.

AI & Machine LearningBiotechDigital Health

Neurolytic Healthcareneurolytic-healthcare.comDec 2021

HealthtechLondon

Roman Rothaermel(Executive Officer, Director, Promoter)Tom Kent(Executive Officer, Director, Promoter)Inna Thalmann(Executive Officer, Director, Promoter)Parul Singh(Director)

Parallelhealthparallelhealth.io in

Parallel Health offers a skincare product line addressing aging through microbiome science, including peptide creams and cleansers designed to target the hallmarks of skin aging.

BiotechConsumerDigital HealthDirect to ConsumerHealthtechWellness & Fitness

Nathan Brown(Founder)in

Co-investorsAxial VC Hyphen Capital

Stempharmstempharm.com in 𝕏

Stem Pharm develops therapeutics using stem cell technology for disease treatment and drug discovery.

BiotechDeep TechHealthtechMedical DevicesNew MaterialsMadison, US

Connie Lebakken(COO)inBill Murphy(CSO)inSteven Visuri(CEO)in Ryan Gordon(Sr. V.P. of Business Development and Commercialization)in

Tailortailor.bio in

Tailor Bio develops targeted cancer therapies for tumors characterized by chromosomal instability, working in the field of precision oncology.

BiotechHealthtech

Co-investorsJIC Venture Growth Investments ANRI New Enterprise Associates (NEA)Spiral Capital Y Combinator

Yali Bioyalibio.com inFeb 2022 · $3.9M

Yali develops fermentation technology to produce sustainable fats and lipids for alternative dairy products like ice cream, butter, and milk, using fewer inputs than conventional sources.

BiotechCleantechClimate TechFoodTech

Co-investorsFTW Ventures S2G Investments CRCM Ventures Third Kind Venture Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AarogyaCognitivegeneticsDoloromicsEpicombiPrenomeWellsimbiotech

Exits · 2

1 IPOs · 1 acquisitions · showing 1

HumacyteNASDAQ: HUMA

Portfolio news

latest coverage across their companies

flowscope: agentic process mining and automation

flowscope · ycombinator.com · May 11, 2026

Jane Street Leads Antithesis's $105M Series A to Make Deterministic Simulation Testing the New Standard

Antithesis · prnewswire.com · Dec 3, 2025

Frequently asked questions

How many investments has First In Ventures made?: First In Ventures has 30 tracked investments, 2 of which have exited, including 1 dated in the last 24 months.
What stage does First In Ventures invest at?: First In Ventures invests at the Pre-Seed, Seed stages.
What is First In Ventures's typical check size?: First In Ventures typically writes checks of $50K – $200K.
What sectors does First In Ventures focus on?: First In Ventures focuses on AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
Where is First In Ventures located?: First In Ventures is headquartered in Middletown, US.
Does First In Ventures lead rounds?: Yes, First In Ventures leads investment rounds.
Who does First In Ventures co-invest with?: First In Ventures most often shares deals with Better Ventures Central Llc, Illumina Ventures, Entrepreneur First, among 29 tracked co-investors.

Images

Similar investors

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

GoAhead Ventures

GoAhead Ventures is a venture capital firm that operates like a startup, using a streamlined one-way video pitch process where all three managing partners review every submission and deliver fast investment decisions.